BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 27
• 28
• 29
• 30

• Business

  RightEye Developing Revolutionary Eye-Tracking Test For Reading Disorders

  December 6, 2016

   · 

  4 min read
• Business

  MPEG LA Initiative To Address CRISPR Licensing

  December 6, 2016

   · 

  2 min read
• FDA

  Boehringer Ingelheim Release: FDA Approves Jardiance (Empagliflozin) Tablets To Reduce The Risk Of Cardiovascular Death In Adults With Type 2 Diabetes And Established Cardiovascular Disease

  December 6, 2016

   · 

  7 min read
• Drug Development

  Seattle Genetics And Bristol-Myers Squibb Highlight First Data From Phase 1/2 Study Evaluating ADCETRIS (Brentuximab Vedotin) In Combination With Opdivo (Nivolumab) In Relapsed Or Refractory Hodgkin Lymphoma At American Society of Hematology Annual Meetin

  December 6, 2016

   · 

  1 min read
• Drug Development

  Celgene Release: Combined Analysis Of Oral Epigenetic Therapy, CC-486, Demonstrated Hematologic Responses In Patients Who Received Prior Epigenetic Hypo-Methylating Agents (HMA)

  December 6, 2016

   · 

  4 min read
• Business

  BioPharmX To Report Third Quarter Financial Results

  December 6, 2016

   · 

  1 min read
• BioMidwest

  Becton, Dickinson and Company Integrating Technology, Expertise And Services To Provide Comprehensive Medication Management

  December 6, 2016

   · 

  5 min read
• Drug Development

  Oncternal Therapeutics’ Pipeline Candidates Featured In Presentations At The American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  7 min read
• Drug Development

  Seattle Genetics Highlights Long-Term Follow-Up Data From ADCETRIS®(Brentuximab Vedotin) In T-Cell Lymphomas At American Society of Hematology Annual Meeting

  December 6, 2016

   · 

  18 min read
• Business

  Nurix Appoints Robert Tjian, Ph.D. Of The Column Group To Its Board Of Directors

  December 6, 2016

   · 

  1 min read